Panagora Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Panagora Asset Management’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-17,512	Closed	-$67K	–	2717
2020 Q1	$67K	Buy	+17,512	New	+$75.4K	﹤0.01%	1820
2018 Q1	–	Sell	-3,581	Closed	-$21K	–	2437
2017 Q4	$21K	Hold	3,581	–	–	﹤0.01%	2168
2017 Q3	$26K	Hold	3,581	–	–	﹤0.01%	2149
2017 Q2	$24K	Hold	3,581	–	–	﹤0.01%	2227
2017 Q1	$34K	Hold	3,581	–	–	﹤0.01%	2078
2016 Q4	$31K	Sell	3,581 -7,806	-69%	-$57.7K	﹤0.01%	2157
2016 Q3	$72K	Sell	11,387 -21,528	-65%	-$130K	﹤0.01%	2046
2016 Q2	$139K	Hold	32,915	–	–	﹤0.01%	1810
2016 Q1	$143K	Sell	32,915 -169,573	-84%	-$755K	﹤0.01%	1765
2015 Q4	$1.24M	Buy	202,488 +12,712	+7%	+$83.3K	0.01%	976
2015 Q3	$1.08M	Buy	189,776 +44,049	+30%	+$338K	0.01%	1001
2015 Q2	$1.09M	Buy	145,727 +134,152	+1,159%	+$812K	0.01%	1056
2015 Q1	$69K	Sell	11,575 -3,611	-24%	-$22.7K	﹤0.01%	2019
2014 Q4	$115K	Hold	15,186	–	–	﹤0.01%	1822
2014 Q3	$79K	Sell	15,186 -6,660	-30%	-$33.2K	﹤0.01%	1922
2014 Q2	$94K	Hold	21,846	–	–	﹤0.01%	1948
2014 Q1	$89K	Hold	21,846	–	–	﹤0.01%	1965
2013 Q4	$116K	Hold	21,846	–	–	﹤0.01%	1814
2013 Q3	$110K	Buy	+21,846	New	+$119K	﹤0.01%	1838

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Panagora Asset Management's PGNX Position: Q2 2020 in Review

Panagora Asset Management sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 17,512 shares — an estimated $67K sold.

Panagora Asset Management first reported a position in PGNX in Q3 2013 and held it in 19 quarters. The position peaked at $1.24M in Q4 2015. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

Panagora Asset Management reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Panagora Asset Management sold 17,512 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $67K.
Panagora Asset Management first reported a position in Progenics Pharmaceuticals Inc in Q3 2013 and held it in 19 quarters.
Panagora Asset Management's Progenics Pharmaceuticals Inc position peaked at $1.24M in Q4 2015.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Panagora Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.